Latest / The Jon and Marc Podcast
New MDLs Formed, J&J’s Talc Defense Verdict, and Major Paraquat Updates
Key Takeaways
Two New MDLs Established: The JPML has officially formed two new mass tort dockets: the Dupixent litigation in the District of New Jersey and the Spinal Cord Stimulator litigation against Boston Scientific in the Central District of California.
Dupixent Injury Focus: The Dupixent MDL targets a rare T-cell subtype of non-Hodgkin lymphoma , drawing from a massive potential pool of roughly 800,000 users and projected to eventually encompass a few thousand cases.
Spinal Cord Stimulator Scope Limited: Plaintiffs requested an industry-wide spinal cord stimulator MDL, but the JPML…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.